RET

From Beacon

RET is a gene that encodes for a receptor tyrosine kinase involved in cell growth, differentiation, and survival. Mutations and fusions involving the RET gene can lead to uncontrolled cell proliferation and are implicated in various cancers, including medullary thyroid cancer, non-small cell lung cancer, and some forms of colorectal cancer. Identifying RET alterations in tumours is vital for determining the best course of treatment, as targeted therapies known as RET inhibitors can specifically block the abnormal RET signaling. These inhibitors have shown promising results in shrinking tumours and improving patient outcomes. Understanding and detecting RET gene mutations and fusions enable personalized cancer treatment, offering more effective and tailored therapeutic options for patients with RET-driven cancers.